China, Aug. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Single-Center Randomized Controlled Clinical Study on the Neuroimmunomodulatory Effect of Stellate Ganglion Block on Sepsis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130088
Registration Time: 2026/08/14
Type: Interventional study
Primary Sponsor: People's Hospital of Anshun city Guizhou Province
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=301529
Published by HT Digital Content Services with permission from Health Daily Digest....